These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 230969)

  • 1. Cyclic neucleotides in progressive muscular dystrophy.
    Kito S; Yamamoto M; Itoga E; Kishida T
    Eur Neurol; 1979; 18(5):356-60. PubMed ID: 230969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The levels of cyclic GMP and glucose 1,6-diphosphate, and the activity of phosphofructokinase, in muscle from normal and dystrophic mice.
    Beitner R; Haberman S; Nordenberg J; Cohen TJ
    Biochim Biophys Acta; 1978 Sep; 542(3):537-41. PubMed ID: 210843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical changes in progressive muscular dystrophy. XI. Cyclic nucleotides in the skeletal and cardiac muscle of normal and dystrophic mice.
    Srivastava U; Sebag M; Thakur M
    Can J Physiol Pharmacol; 1981 Apr; 59(4):329-34. PubMed ID: 6263431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycogen cycle enzymes and cyclic nucleotides in avian muscular dystrophy.
    Schliselfeld LH; Anderson DM
    Muscle Nerve; 1980; 3(2):128-33. PubMed ID: 6245356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Skeletal muscle protein and amino acid metabolism in hereditary mouse muscular dystrophy. The role of disordered cyclic nucleotide metabolism in the accelerated alanine and glutamine formation and release.
    Garber AJ; Birnbaumer L; Bornet EP; Thompson WJ; Entman ML
    J Biol Chem; 1980 Sep; 255(17):8325-33. PubMed ID: 6251052
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphodiesterase activity in muscles of control and dystrophic mice.
    Garbagna L; Cojazzi M; Marcucci F; Mussini E
    Res Commun Chem Pathol Pharmacol; 1981 Mar; 31(3):537-44. PubMed ID: 6265991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The purine nucleotide profile in mouse, chicken and human dystrophic muscle: an abnormal ratio of inosine plus adenine nucleotides to guanine nucleotides.
    Shuttlewood RJ; Griffiths JR
    Clin Sci (Lond); 1982 Jan; 62(1):113-5. PubMed ID: 7056028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of cyclic nucleotides in healthy and diseased human muscle.
    Canal N; Cerri C; Musch B; Frattola L
    Isr J Med Sci; 1977 Feb; 13(2):147-51. PubMed ID: 193806
    [No Abstract]   [Full Text] [Related]  

  • 9. Intracellular protein degradation in cultures of dystrophic muscle cells and fibroblasts.
    McElligott MA; Dice JF
    Exp Cell Res; 1984 Feb; 150(2):442-51. PubMed ID: 6363108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K
    J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a maturation defect related to calcium in muscle mitochondria from dystrophic mice and Duchenne and Becker muscular dystrophy patients.
    Lucas-Héron B; Mussini JM; Ollivier B
    J Neurol Sci; 1989 May; 90(3):299-306. PubMed ID: 2738610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abnormalities in membrane microviscosity and ion transport in genetic muscular dystrophy.
    Sha'afi RI; Rodan SB; Hintz RL; Fernandez SM; Rodan GA
    Nature; 1975 Apr; 254(5500):525-6. PubMed ID: 1121326
    [No Abstract]   [Full Text] [Related]  

  • 13. Cyclic nucleotide metabolism in neuromuscular disease.
    Brooks BR; Sode J; Engel WK
    UCLA Forum Med Sci; 1976; (19):101-18. PubMed ID: 191963
    [No Abstract]   [Full Text] [Related]  

  • 14. [Study of the components of the cAMP system in muscle tissue in progressive muscular dystrophy (Erb's form) and myasthenic myopathy].
    Kozlov AV; Korovkin BF; Lobzin VS; Shapkin VI
    Lab Delo; 1979; (8):468-9. PubMed ID: 89254
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclic 3',5'-AMP metabolism in progressive muscular dystrophy patients].
    Khokhlov AP; Malakhovskiĭ VK
    Vopr Med Khim; 1978; 24(6):754-8. PubMed ID: 216142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in cyclic necleotides in dogs after triiodothyronine.
    Fernandez-Pol JA; Hays MT
    Acta Endocrinol (Copenh); 1975 May; 79(1):66-75. PubMed ID: 165647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclic 3--5-adenosine monophosphate metabolism in patients with Duchenne myodystrophy].
    Khokhlov AP; Il'ina NA; Malakhovskiĭ VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(5):474-7. PubMed ID: 208332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Human myopathy and animal muscular dystrophy].
    Schapira G; Dreyfus JC; Schapira F
    Acta Zool Pathol Antverp; 1977 Aug; (68):93-110. PubMed ID: 335859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine.
    Bernasconi P; Torchiana E; Confalonieri P; Brugnoni R; Barresi R; Mora M; Cornelio F; Morandi L; Mantegazza R
    J Clin Invest; 1995 Aug; 96(2):1137-44. PubMed ID: 7635950
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Control of levels of glucose 1,6-bisphosphate.
    Beitner R
    Int J Biochem; 1984; 16(6):579-85. PubMed ID: 6088312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.